A blocked coronary artery causing an acute heart attack must be opened immediately with a stent procedure. However, if other ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

This review aims to provide an insight into the prognostic impact of perioperative stent thrombosis, in order to offer clarification on the mechanisms related to the devastating effect of stent ...

Update: This story has been corrected to reflect the source of 12-month data for the PRO-Kinetic device. It comes from the previous ENERGY Registry study, and not from the BIOHELIX-1 study. Biotronik ...

Surgeons in the United States perform nearly 600,000 coronary artery stent procedures and bypass surgeries every year.

More than a fifth of all coronary stents given to Medicare patients at hospitals nationwide from 2019 to 2021 are medically unnecessary, driving more than $2.4 billion in unnecessary program spending ...

A bioadaptor implant that actively adapts to vessel physiology was linked to lower target lesion failure and target vessel ...

XIENCE Xpedition™ 48 Leverages Proven Design and Clinical Outcomes of the XIENCE Family of Drug Eluting Stents Has the Potential to Reduce Overall Procedural Costs Very Long Lesions Most Often Seen in ...

SAN ANTONIO. -- CeloNova BioSciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted approval to start an investigative device exemption (IDE) trial for its novel ...

CeloNova BioSciences Inc. announced its novel first-in-class nanocoated coronary stent system has received FDA approval following the results of the of the PzF SHIELD clinical trial. The stent (Cobra ...

The delivery of coronary artery stents is a procedure that affects over 1 million patients each year in the United States. With an aging population, the declining cost of stents, and reimbursement ...